Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Understand when to use Zero Based Budgeting versus Traditional budgeting, with scenarios where each approach delivers the most value and clarity.
23,185 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Boyd Group stock since its IPO has posted a meaningful climb. This piece breaks down the factors behind the move, wha...
Investors are watching Innovative Industrial Properties stock climb this week as earnings and leasing momentum paint ...
A broad selloff descends into rout in South Korea, sending the KOSPI to its worst daily decline in 16 years. Margin c...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
After a slow season, many sellers paused listings. If 75,000 relistings occur, demand could rise without a flood of n...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
Gold is leading gains in early 2026, while silver remains volatile. Analysts say the evolving ETF landscape is paving...
When markets wobble, resilient essentials stocks shine. Meet three proven picks that have stood the test of time: Pro...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...